Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life.
"The prevalence of these symptoms accounts for a huge variance in physical, mental and social domains of quality of life among survivors," said I-Chan Huang, Ph.D., an associate professor of health outcomes and policy in the UF College of Medicine and the lead author of the study. "If we think symptoms are the key to patients' quality of life, then if we can better manage their symptoms, we can improve their daily functional status and quality of life."
Huang, also a member of UF's Institute for Child Health Policy, teamed with researchers from St. Jude Children's Research Hospital in Memphis to conduct the study, which was published in the Journal of Clinical Oncology.
The researchers analyzed data from 1,667 childhood cancer survivors who participated in a St. Jude study looking at the long-term effects of cancer survival. The researchers used a patient-reported survey to measure quality of life. A specific symptom scale was designed to assess toxicities related to cancer treatment, as outlined in the Children's Oncology Group guidelines.
The most common symptoms patients reported were head pain, pain in the back and neck, pain in areas other than the back and neck, disfigurement such as hair loss and sensation abnormalities.
According to the research findings, participants' ratings of their own physical and mental quality of life dipped lower and lower for each additional symptom they reported. Participants also reported more symptoms over time, with survivors reporting late effects up to 40 years after they were initially diagnosed with cancer. According to a report from the Institute of Medicine, approximately one in every 600 adults between the ages of 20 to 39 is a survivor of childhood cancer.
About 70 percent of participants reported experiencing at least one late effect from their cancer. One-quarter of participants reported experiencing six or more late effects.
Because the study did not account for fatigue or sleep disturbances, the actual percentage of survivors who experience late effects from cancer that affect quality of life could be even higher, Huang said.
The next step, Huang noted, is developing a tool kit to help physicians use this information in practice to help cancer survivors improve their quality of life. Although tools have been devised to make it easier for doctors to measure a patient's quality of life when they visit the doctor, physicians often don't know what to do with this information.
Because of this uncertainty and limited time and staff, only 16 percent of clinicians use quality of life measures in practice, according to a recent national survey Huang conducted on pediatricians' and subspecialists' attitudes and the barriers to assessing pediatric quality of life. Helping physicians calculate and interpret quality-of-life scores and better use this data to communicate with patients in decision-making processes is important, because the measures take into account health issues that affect patients' day-to-day lives.
"We need to provide clear guidance about quality of life and a different structure to use patient-reported outcomes in clinical settings," Huang said. "The critical step is to develop a methodology to diagnose quality of life of individual cancer patients or survivors. We are working to develop a diagnostic classification system by focusing on individualized attributes of poor quality of life; symptoms are one of the key, proximal attributes."
This study was supported by the National Cancer Institute Cancer Center Support Grant No. CA21765.
Association Between the Prevalence of Symptoms and Health-Related Quality of Life in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study, I-Chan Huang, Tara M. Brinkman, Kelly Kenzik, James G. Gurney, Kirsten K. Ness, Jennifer Lanctot, Elizabeth Shenkman, Leslie L. Robison, Melissa M. Hudson and Kevin R. Krull, JCO - doi: 10.1200/JCO.2012.47.8867
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Pediatrics / Children's Health category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Health, UF. "Study shows symptoms linked to poor quality of life in long-term childhood cancer survivors." Medical News Today. MediLexicon, Intl., 16 Dec. 2013. Web.
7 Mar. 2014. <http://www.medicalnewstoday.com/releases/270144>
Health, U. (2013, December 16). "Study shows symptoms linked to poor quality of life in long-term childhood cancer survivors." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270144.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.